International Cycling Union (UCI) Colombian cyclist this Wednesday Nairo Quintana punished for violating the prohibition of use. tramadol In the light of the secondary effects of this substance, in the competition determined in the UCI Medical Regulations in order to protect the safety and health of cyclists.
UCI reports that “analysis of two dry blood samples provided by the cyclist on 8 and 13 July Tour de France 2022 revealed the presence of tramadol and its two major metabolites”.
Under UCI Medical Rules, the rider is disqualified from the 2022 Tour de France. This decision can be appealed. Sports Arbitration Court (TAS) in the next 10 days.
The UCI reports that a total of 120 dry blood samples were collected as part of the tramadol program during the 2022 Tour de France.
(You may be interested in: Nairo Quintana: This is the item they disqualified him from the Tour)
“Violation of the ban on the use of tramadol in competitions is a crime under the UCI Medical Regulations. They do not constitute anti-doping rule violations. Nairo Alexander Quintana Rojas is not declared indecent as a first offense and therefore can participate in competitions.
The UCI said in a statement that it would not comment further on the matter.
As of March 1, 2019, the UCI has banned the use of tramadol in competitions in all disciplines and categories in order to protect the health and safety of cyclists from the side effects of this substance.
Samples are collected by the International Testing Agency (ITA) using the Dried Blood Points (DBS) reference method. Sampling kits are used to perform this minimally invasive test, which involves drawing a small amount of blood from the cyclist’s fingertip, developed by Swiss company DBS Systems.
You can find the regulation on the tramadol ban here.